KATARZYNA LALICATA: Open Payments
NPI 1811316110 · EL CAJON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$144 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $172 · 2025 $144
Food & beverage: $144
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $71 |
| Astellas Pharma US Inc | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
| ABIOMED | 1 | $15 |
Products named: Veozah, PAXLOVID, TZIELD.
Industry payments across CA — which companies pay providers there.
